Quantification of Statins in Pharmaceutical Products Using Screen-Printed Sensors Based of Multi-Walled Carbon Nanotubes and Gold Nanoparticles

This study describes the use of electrochemical sensors to detect and quantify several statins (rosuvastatin and simvastatin) in pharmaceutical products. Two types of commercially screen-printed sensors were used and compared: one based on carbon (SPCE) and the other modified with gold nanoparticles and multi-walled carbon nanotubes (SPE/GNP-MWCNT). Cyclic voltammetry was employed for determination. The AuNP-MWCNTs/SPCE sensor outperformed the SPCE sensor, displaying excellent electrochemical properties. It demonstrated high sensitivity with low limits of detection (LOD) and quantification (LOQ) values: 0.15 µM and 5.03 µM, respectively, for rosuvastatin and 0.30 µM and 1.01 µM, respectively, for simvastatin. The sensor had a wide linear range of 20–275 µM for rosuvastatin and 50–350 µM for simvastatin. Using the AuNP-MWCNTs/SPCE sensor, rosuvastatin and simvastatin were successfully quantified in pharmaceutical products. The results were validated towards producer-reported values (standardized drugs) and a conventional analysis method (FTIR). The sensor exhibited excellent stability, reproducibility, and analytical recovery ranging from 99.3% to 106.6% with a low relative standard deviation (RSD) of less than 1%. In conclusion, the AuNP-MWCNTs/SPCE sensor proved to be a reliable and sensitive tool for detecting and quantifying statins in pharmaceutical products. Its superior electrochemical properties, low LOD and LOQ values, wide linear range, and high analytical recovery make it a promising choice for pharmaceutical quality control.